SPOTLIGHT: Avandia critic an industry watchdog


So what's the story with Dr. Steven Nissen? The cardiologist who chairs the Cleveland Clinic's department of cardiovascular medicine made international headlines when he released a study suggesting that blockbuster diabetes drug Avandia posed greater heart health risks than expected. But this isn't the first time that Nissen has had a major impact on the drug industry. For years, Nissen has been an influential watchdog, respected by legislators on Capitol Hill and feared by pharmas. Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.